Sciformix Corporation CSO Honoured in PharmaVOICE 100
News Aug 01, 2014
Sciformix Corporation has announced that Dr. Chitra Lele, Chief Scientific Officer, has been named in the top 100 most inspiring people in the life sciences industry by PharmaVOICE magazine. Dr. Lele was selected from distinguished nominees that represent a broad cross section of life science sectors based on affecting positive changes within their companies and the industry at large. Dr. Lele has been recognized for her ability to view industry trends as challenges not burdens, and as opportunities not obstacles; her passion and conviction for the industry; her ability to innovate and think outside of the box and develop breakthrough strategies, products, and services; for pioneering new paths and lifting her company to new heights.
With over a 20 year career in pharma, Dr. Lele has played a pioneering role in the creation and implementation of a globally distributed outsourcing model for key product lifecycle support services, including biometrics, scientific writing, safety and risk management, and regulatory affairs. By operationalizing a globally distributed model to support the design, analysis, and reporting of clinical trials, specifically regarding the offshoring of biometrics and medical writing, Chitra facilitated a change in the way the pharma industry started looking at sourcing clinical trial related services, leading to a permanent shift in the industry’s operational model and opening up new frontiers.
Dr. Lele has been instrumental in establishing Sciformix Corporation in all respects, from the management of operations and delivery, to strategizing the organizational path and trajectory, growing the business and laying down the foundations of the organization which has been conducive to its growth. Chitra has been integral to the success of the company, chartering the path of Sciformix by determining services to focus on across a number of segments, the geographies to grow in, partnership models suited for each service line and the conceptualization of new solutions and offerings.
Manish Soman, President and CEO at Sciformix, said: “Chitra’s astute management and leadership skills have been vital to Sciformix’s growth, and have been truly reflected in the company’s success. She has enabled us to push the boundaries within the life sciences sector, and is instrumental in shaping and positioning Sciformix as an SPO. Chitra has expanded the global reach of Sciformix for the services we offer by directing us to where the talent pool is based, in order to provide the best quality support to our clients.”
He continued: “This helps when developing partnerships across stakeholders, including the CRO’s and the regulators, in addition to the pharmaceutical and healthcare companies. Together with this, Chitra has evolved new, niche solutions and service offerings in areas of safety signal detection and post-approval services based on emerging trends. It is fantastic for her to have received this recognition for her hard work and commitment.”
Dr. Lele commented: “To be honoured by my peers for making a major contribution in this area and to the overall advancement of our industry is very gratifying. I find that while it is fantastic to look at previous achievements, our industry is in a very dynamic state, and we need to concentrate our efforts on the challenges ahead to break through to new horizons; electronic health records, social media and ‘Big Data’ are forcing a revolution that we have to embrace. With new operating and partnership models emerging across product development and lifecycle maintenance, new cross functional and technology-based innovative offerings are the need of the hour, and I will be putting my efforts into initiatives at Sciformix that will fulfil this need of the industry now and moving forward into the future.”
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE AntibodiesNews
The project will add to IGEM’s pipeline of drugs and expand upon IGEM-F, an IgE targeting ovarian and other cancers, currently in a Phase 1/2a study.READ MORE
Comments | 0 ADD COMMENT
16th Annual Conference on Laboratory Medicine and Pathology
Sep 17 - Sep 18, 2018